[
  {
    "ts": null,
    "headline": "Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of Collagen VII, a complex therapeutic target critical to Z",
    "url": "https://finnhub.io/api/news?id=e41b7eeaacf3124d4e4878190395180acc5ade61d89a89e0c774bc4627c31583",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752490800,
      "headline": "Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy",
      "id": 135925856,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of Collagen VII, a complex therapeutic target critical to Z",
      "url": "https://finnhub.io/api/news?id=e41b7eeaacf3124d4e4878190395180acc5ade61d89a89e0c774bc4627c31583"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne's Simple Western? Technology Utilized in Recent Fda Approval of Zevaskyn Cell-Based Gene Therapy",
    "summary": "Bio-Techne Corporation announced that its Simple Western? Technology played a key role in supporting the FDA approval of ZEVASKYN? , the first autologous cell-based gene therapy for patients with...",
    "url": "https://finnhub.io/api/news?id=4878233f0800026414e20621305b1ff130cbfc56bf73fb2937d610dfddf446d8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752479446,
      "headline": "Bio-Techne's Simple Western? Technology Utilized in Recent Fda Approval of Zevaskyn Cell-Based Gene Therapy",
      "id": 135923013,
      "image": "",
      "related": "TECH",
      "source": "Finnhub",
      "summary": "Bio-Techne Corporation announced that its Simple Western? Technology played a key role in supporting the FDA approval of ZEVASKYN? , the first autologous cell-based gene therapy for patients with...",
      "url": "https://finnhub.io/api/news?id=4878233f0800026414e20621305b1ff130cbfc56bf73fb2937d610dfddf446d8"
    }
  }
]